The therapeutic interventions for pulmonary arterial hypertension (PAH) have predominantly focused on facilitating pulmonary blood flow by inducing vasodilation to reduce the mechanical resistance against the right ventricle (RV) ...
Vassiliou et al. (Wed,) studied this question.